pSivida sells AION Diagnostics for $3.6m

Perth-headquartered bio-nanotech company pSivida Ltd has sold its subsidiary AION Diagnostics Inc to US-based private equity group GEM Global Yield Fund for around $3.6 million, following the company's float on the Frankfurt Stock Exchange.

 

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Register for free

(first time users)
FREE: 8 articles per month + twice daily business email alerts
Category: 
Tags:

Comments:

Exporters

LabelValue
Rio Tinto$21.40bn
BHP Billiton Iron Ore$17.97bn
North West Shelf Venture$16.84bn
Fortescue Metals Group$8.12bn
Gold Corporation$5.81bn
Others$53.80bn
Did you know 20
Did you know 21
Did you know 19
Did you know 18
Did you know 17
Did you know 16
Did you know 15
Did you know 14
Did you know 13
Did you know 12
Did you know 11
Did you know 10
Did you know 9
Did you know 8
Did you know 7
Did you know 6
Did you know 5
Did you know 4
Did you know 3
Did you know 2
Did you know 1

Feedback Form